Standards for the development and methodology of the 2023 IWGDF guidelines
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Aims: Diabetes‐related foot disease is a major source of patient burden and societal costs. Investing in evidence‐based international guidelines on diabetes‐related foot disease is important to reduce this burden and costs, provided the guidelines are focused on outcomes important to key stakeholders and are evidence‐based and properly implemented. Materials and Methods: The International Working Group on the Diabetic Foot (IWGDF) has published and updated international guidelines since 1999. The 2023 updates were made using the Grading of Recommendations Assessment Development and Evaluation evidence‐to‐decision framework. This concerns formulating relevant clinical questions and important outcomes, conducting systematic reviews of the literature and meta‐analyses where appropriate, completing summary of judgement tables, and writing recommendations that are specific, unambiguous and actionable, along with their transparent rationale. Results: We herein describe the development of the 2023 IWGDF Guidelines on the prevention and management of diabetes‐related foot disease, which consists of seven chapters, each prepared by a separate working group of international experts. These chapters provide guidelines related to diabetes‐related foot disease on prevention; classification of diabetes‐related foot ulcer, offloading, peripheral artery disease, infection, wound healing interventions, and active Charcot neuro‐osteoarthropathy. Based on these seven guidelines, the IWGDF Editorial Board also produced a set of practical guidelines. Each guideline underwent extensive review by the members of the IWGDF Editorial Board as well as independent international experts in each field. Conclusions: We believe that the adoption and implementation of the 2023 IWGDF guidelines by healthcare providers, public health agencies, and policymakers will improve the prevention and management of diabetes‐related foot disease, and subsequently reduce the worldwide patient and societal burden caused by this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rayyan-a web and mobile app for systematic reviews.
Ouzzani, M., Hammady, H., Fedorowicz, Z., & Elmagarmid, A. (2016) · Systematic Reviews · doi:10.1186/s13643-016-0384-4 · Cited by 26,092
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003583 · Cited by 5,148
Diabetic foot ulcers and their recurrence
Armstrong, D. G., Boulton, A. J. M., & Bus, S. A. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1615439 · Cited by 4,376
Self-citationMcInnes, M. D. F., Moher, D., Thombs, B. D., McGrath, T. A., Bossuyt, P. M., and the PRISMA-DTA Group, Clifford, T., Cohen, J. F., Deeks, J. J., Gatsonis, C., et al. (2018) · JAMA · doi:10.1001/jama.2017.19163 · Cited by 3,210
A new system for grading recommendations in evidence based guidelines
Harbour, R., & Miller, J. (2001) · BMJ · doi:10.1136/bmj.323.7308.334 · Cited by 1,637
Alonso-Coello, P., Oxman, A. D., Moberg, J., Brignardello-Petersen, R., Akl, E. A., Davoli, M., Treweek, S., Mustafa, R. A., Vandvik, P. O., Meerpohl, J., et al. (2016) · BMJ · doi:10.1136/bmj.i2089 · Cited by 814
Jeffcoate, W. J., Bus, S. A., Game, F. L., Hinchliffe, R. J., Price, P. E., & Schaper, N. C. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30012-2 · Cited by 234
Self-citationBrownrigg, J. R. W., Hinchliffe, R. J., Apelqvist, J., Boyko, E. J., Fitridge, R., Mills, J. L., Reekers, J., Shearman, C. P., Zierler, R. E., Schaper, N. C., et al. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2704 · Cited by 130 · cited 1×
“25 To assess the methodological quality of the included studies, we used the Quality in Prognostic Studies (QUIPS) tool designed specifically for prognostic studies.”
MethodSelf-citationMonteiro-Soares, M., Vale-Lima, J., Martiniano, J., Pinheiro-Torres, S., Dias, V., & Boyko, E. J. (2021) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107837 · Cited by 55
Self-citation
Research works printed but not linked: 19
- International Diabetes Federation, 2021, IDF Diabetes Atlas
- 10.2337/dc19‐1614 · DOI · Paper page
- 10.1016/s0140‐6736(05)67698‐2 · DOI · Paper page
- 10.2337/dc06‐0306 · DOI · Paper page
- 10.1007/s00125‐008‐0940‐0 · DOI · Paper page
- 10.1002/dmrr.2245 · DOI · Paper page
- 10.1111/dme.14961 · DOI
- 10.1002/dmrr.3268 · DOI · Paper page
- 10.1136/bmj.i2089 · DOI · Paper page
- 10.1002/dmrr.2703 · DOI · Paper page
- 10.1186/1471‐2288‐3‐25 · DOI · Paper page
- 10.1001/jama.271.5.389 · doi:10.1001/jama.271.5.389 · Paper page
- 10.1001/jama.271.9.703 · doi:10.1001/jama.271.9.703 · Paper page
- 10.7326/0003‐4819‐158‐4‐201302190‐00009 · DOI · Paper page
- 10.7326/0003‐4819‐144‐6‐200603210‐00010 · DOI · Paper page
- 10.12968/jowc.2017.26.6.324 · DOI
- 10.1002/dmrr.2738 · DOI · Paper page
- 10.1016/j.diabres.2006.05.014 · DOI
- 10.1186/1475‐2840‐11‐18 · DOI
Cited by
Schaper, N. C., van Netten, J. J., Apelqvist, J., Bus, S. A., Fitridge, R., Game, F., Monteiro‐Soares, M., Senneville, E., & the IWGDF Editorial Board (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3657 · Cited by 583
Self-citationSenneville, É., Albalawi, Z., van Asten, S. A., Abbas, Z. G., Allison, G., Aragón‐Sánchez, J., Embil, J. M., Lavery, L. A., Alhasan, M., Oz, O., et al. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3687 · Cited by 498
Self-citationGuidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2023 update)
Bus, S. A., Sacco, I. C. N., Monteiro‐Soares, M., Raspovic, A., Paton, J., Rasmussen, A., Lavery, L. A., & van Netten, J. J. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3651 · Cited by 279
Self-citationFitridge, R., Chuter, V., Mills, J., Hinchliffe, R., Azuma, N., Behrendt, C., Boyko, E. J., Conte, M. S., Humphries, M., Kirksey, L., et al. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3686 · Cited by 201
Self-citationSenneville, É., Albalawi, Z., van Asten, S. A., Abbas, Z. G., Allison, G., Aragón-Sánchez, J., Embil, J. M., Lavery, L. A., Alhasan, M., Oz, O., et al. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad527 · Cited by 192
Guidelines on offloading foot ulcers in persons with diabetes—IWGDF 2023 update.
Bus, S. A., Armstrong, D. G., Crews, R. T., Gooday, C., Jarl, G., Kirketerp‐Moller, K., Viswanathan, V., & Lazzarini, P. A. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3647 · Cited by 169
Self-citationGuidelines on the classification of foot ulcers in people with diabetes (IWGDF 2023 update).
Monteiro‐Soares, M., Hamilton, E. J., Russell, D. A., Srisawasdi, G., Boyko, E. J., Mills, J. L., Jeffcoate, W., & Game, F. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3648 · Cited by 152
Metadata
- Authors
- Bus, S. A., Monteiro‐Soares, M., Game, F., van Netten, J. J., Apelqvist, J., Fitridge, R., Senneville, E., Schaper, N. C., & IWGDF Editorial Board
- Venue
- Diabetes/Metabolism Research and Reviews
- Publisher
- Wiley
- Published
- 2023-05-14
- Volume
- 40
- Issue
- 3
- Pages
- e3656-e3656
- ISSN
- 1520-7552 (ISSN-L)
- 1520-7560
- OpenAlex
- W4376598557
- Cited by
- 27
- References
- 10
- FWCI
- 4.47
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.